ES2052759T3 - Procedimiento para la obtencion de poliosidos capsulares de estafilococos, aplicaciones de estos poliosidos y cepas para la puesta en practica del procedimiento. - Google Patents

Procedimiento para la obtencion de poliosidos capsulares de estafilococos, aplicaciones de estos poliosidos y cepas para la puesta en practica del procedimiento.

Info

Publication number
ES2052759T3
ES2052759T3 ES88401996T ES88401996T ES2052759T3 ES 2052759 T3 ES2052759 T3 ES 2052759T3 ES 88401996 T ES88401996 T ES 88401996T ES 88401996 T ES88401996 T ES 88401996T ES 2052759 T3 ES2052759 T3 ES 2052759T3
Authority
ES
Spain
Prior art keywords
procedure
capsular
obtaining
staphylococces
poliosids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES88401996T
Other languages
English (en)
Inventor
Jean-Michel Fournier
Anne Bouvet
Alain Boutonnier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur filed Critical Institut Pasteur
Application granted granted Critical
Publication of ES2052759T3 publication Critical patent/ES2052759T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/14—Streptococcus; Staphylococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/305—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F)
    • G01N2333/31—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/882—Staphylococcus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/882—Staphylococcus
    • Y10S435/883—Staphylococcus aureus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Saccharide Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Medicinal Preparation (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA INVENCION TIENE POR OBJETO UN PROCEDIMIENTO DE OBTENCION DE POLIOXIDOS CAPSULARES CARACTERISTICOS DE STAPHYLOCOCCUS AUREUS CARACTERIZADO PRQUE, PARA OBTENER LOS POLIOXIDOS SE UTILIZAN CEPAS DE ESTAFILOCOCOS COAGULASE NEGATIVO. LOS POLIOXIDOS CAPSULARES OBTENIDOS PUEDEN SER UTILIZADOS PARA LA PREPARACION DE VACUNAS CONTRA STAPHYLOCOCCUS AUREUS Y DE PRODUCTOS DE DIAGNOSTICO.
ES88401996T 1987-08-03 1988-07-29 Procedimiento para la obtencion de poliosidos capsulares de estafilococos, aplicaciones de estos poliosidos y cepas para la puesta en practica del procedimiento. Expired - Lifetime ES2052759T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8711006A FR2619122B1 (fr) 1987-08-03 1987-08-03 Procede d'obtention de polyosides capsulaires de staphylocoques, polyosides obtenus, applications de ces polyosides et souches pour la mise en oeuvre du procede

Publications (1)

Publication Number Publication Date
ES2052759T3 true ES2052759T3 (es) 1994-07-16

Family

ID=9353830

Family Applications (1)

Application Number Title Priority Date Filing Date
ES88401996T Expired - Lifetime ES2052759T3 (es) 1987-08-03 1988-07-29 Procedimiento para la obtencion de poliosidos capsulares de estafilococos, aplicaciones de estos poliosidos y cepas para la puesta en practica del procedimiento.

Country Status (11)

Country Link
US (1) US4902616A (es)
EP (1) EP0302781B1 (es)
JP (1) JPH01128793A (es)
AT (1) ATE82134T1 (es)
CA (1) CA1320466C (es)
DE (1) DE3875850T2 (es)
DK (1) DK173564B1 (es)
ES (1) ES2052759T3 (es)
FR (1) FR2619122B1 (es)
GR (1) GR3006613T3 (es)
PT (1) PT88166B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5055455A (en) 1988-09-28 1991-10-08 Brigham And Women's Hospital Capsular polysaccharide adhesin antigen, preparation, purification and use
GB8906794D0 (en) * 1989-03-23 1989-05-10 Carroll Noel Preparation of vaccines
US7279162B1 (en) * 1990-10-22 2007-10-09 Henry M. Jackson Foundation For The Advancement Of Military Medicine Isolated broadly reactive opsonic immunoglobulin for treating a pathogenic coagulase-negative staphylococcus infection
DE69233012T2 (de) * 1991-11-22 2003-11-06 Fattom, Ali Ibrahim Mit staphylococcus epidermidis assoziierte oberflächenantigene des typs i
US5770208A (en) * 1996-09-11 1998-06-23 Nabi Staphylococcus aureus B-linked hexosamine antigen
US5837482A (en) * 1997-01-23 1998-11-17 Minnesota Mining And Manufacturing Company Culture medium and methods for detecting staphylococci
US6610293B1 (en) 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
US7250494B2 (en) * 1998-06-15 2007-07-31 Biosynexus Incorporated Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria
US7252828B2 (en) 1998-07-15 2007-08-07 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
EP1096952B1 (en) * 1998-07-15 2008-05-21 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
US20020092987A1 (en) * 1998-09-05 2002-07-18 Taehee Cho Photo detect device using quantum dots and materialization method thereof
US6936258B1 (en) 1999-03-19 2005-08-30 Nabi Biopharmaceuticals Staphylococcus antigen and vaccine
US7119172B2 (en) * 2001-05-21 2006-10-10 The Brigham And Women's Hospital, Inc. P. aeruginosa mucoid exopolysaccharide specific binding peptides
US6962813B2 (en) * 2001-05-21 2005-11-08 The Brigham And Women's Hospital, Inc. P. aeruginosa mucoid exopolysaccharide specific binding peptides
WO2004043405A2 (en) 2002-11-12 2004-05-27 The Brigham And Women's Hospital, Inc. Polysaccharide vaccine for staphylococcal infections
AU2003290867A1 (en) 2002-11-12 2004-06-03 The Brigham And Women's Hospital, Inc. Methods and products for treating staphylococcal infections
JP2007518074A (ja) * 2003-12-30 2007-07-05 スリーエム イノベイティブ プロパティズ カンパニー 細胞の細胞壁構成成分のシグナル検出を増強する方法
US7399609B2 (en) * 2003-12-30 2008-07-15 3M Innovative Properties Company Staphylococcus detection
AU2005236068C1 (en) 2004-04-21 2012-08-30 Beth Israel Deaconess Medical Center, Inc. Poly-N-acetyl glucosamine (PNAG/DPNAG)-binding peptides and methods of use thereof
US20060062779A1 (en) * 2004-09-21 2006-03-23 The Brigham And Women's Hospital, Inc. Methods and compositions relating to mannuronic acid specific binding peptides
EP2185190B1 (en) * 2007-08-31 2015-06-24 University Of Chicago Methods and compositions related to immunizing against staphylococcal lung diseases and conditions
US9181329B2 (en) 2007-08-31 2015-11-10 The University Of Chicago Methods and compositions related to immunizing against Staphylococcal lung diseases and conditions
KR20110031393A (ko) 2008-07-21 2011-03-25 더 브리검 앤드 우먼즈 하스피털, 인크. 합성 베타-1,6 글루코사민 올리고당에 관한 방법 및 조성물
WO2010014304A1 (en) * 2008-07-29 2010-02-04 University Of Chicago Compositions and methods related to staphylococcal bacterium proteins
ES2784957T3 (es) 2009-04-03 2020-10-02 Univ Chicago Composiciones y métodos relacionados con variantes de la proteína A (SPA)
JP6002128B2 (ja) 2010-07-02 2016-10-05 ザ・ユニバーシティ・オブ・シカゴＴｈｅ Ｕｎｉｖｅｒｓｉｔｙ Ｏｆ Ｃｈｉｃａｇｏ プロテインＡ（ＳｐＡ）変種に関連する組成物および方法
BR112013024322B1 (pt) 2011-03-22 2020-04-22 Serum Inst India Ltd processo para preparação de polissacarídeos
US8945588B2 (en) 2011-05-06 2015-02-03 The University Of Chicago Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
WO2020163512A1 (en) 2019-02-05 2020-08-13 The Brigham And Women's Hospital, Inc. Polysaccharide compositions for use in treating filariasis
MX2021013833A (es) 2019-05-14 2022-03-17 Univ Chicago Metodos y composiciones que comprenden variantes de la proteina a de estafilococos (spa).
WO2021051136A1 (en) 2019-09-13 2021-03-18 The University Of Chicago Methods and compositions for treating staphylococcal infections

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4123520A (en) * 1977-08-01 1978-10-31 Merck & Co., Inc. Method for preparing high molecular weight meningococcal Group C vaccine
JPS5452794A (en) * 1977-09-30 1979-04-25 Kousaku Yoshida Extracting of polysacchride from capusle containing epidermis staphylococus
US4221906A (en) * 1979-03-19 1980-09-09 American Cyanamid Company Stabilization of pneumococcal polysaccharides
FR2475900A1 (fr) * 1980-02-20 1981-08-21 Fabre Sa Pierre Complexe vaccinal contenant un antigene specifique et vaccin le contenant

Also Published As

Publication number Publication date
FR2619122A1 (fr) 1989-02-10
GR3006613T3 (es) 1993-06-30
DK433488A (da) 1989-02-04
DK433488D0 (da) 1988-08-03
CA1320466C (en) 1993-07-20
JPH01128793A (ja) 1989-05-22
ATE82134T1 (de) 1992-11-15
US4902616A (en) 1990-02-20
PT88166B (pt) 1995-07-03
DK173564B1 (da) 2001-03-12
FR2619122B1 (fr) 1990-03-09
DE3875850T2 (de) 1993-06-09
EP0302781A1 (fr) 1989-02-08
EP0302781B1 (fr) 1992-11-11
PT88166A (pt) 1989-06-30
DE3875850D1 (de) 1992-12-17

Similar Documents

Publication Publication Date Title
ES2052759T3 (es) Procedimiento para la obtencion de poliosidos capsulares de estafilococos, aplicaciones de estos poliosidos y cepas para la puesta en practica del procedimiento.
IT987053B (it) Endoprotesi della parte prossi male del femore
IT954548B (it) Procedimento per la fabbricazione di spezzoni tubolari curvi
IT8023628A0 (it) Procedimento per la fabbricazione del silicato sodico.
IT999559B (it) Procedimento per la fabbricazione del gesso
AR201667A1 (es) Procedimiento para la fabricacion de ampollas y ampolletas de vidrio y maquina para la realizacion del procedimiento
ES432696A1 (es) Procedimiento de preparacion de vacunas.
IT985602B (it) Procedimento per la preparazione di pirosolfito sodico
ES8406500A1 (es) Procedimiento para la preparacion de derivados de beta-d-galactosa
AR199893A1 (es) Procedimiento para la preparacion de prostaglandinas e intermediarios particularmente utiles para su preparacion
AT352258B (de) Kupplung fuer zahnaerztliche handstuecke
AR200155A1 (es) Procedimiento para atenuar un coronavirus de la diarrera del ternero y procedimiento para producir una vacuna contra dicha diarrea
IT1056018B (it) Struttura per realizzare una camera ad aria ambiente sterile entro una camera operatoria
ES2059373T3 (es) Extractos de la especie nerium, sus procedimientos de fabricacion y su utilizacion.
ES494598A0 (es) Procedimiento para preparar una vacuna inactivada de reo-vi-rus
AR205205A1 (es) Procedimiento para la preparacion de una vacuna contra el mal de chagas
IT1041904B (it) Procedimento per la preparazione di derivati del cicloesano otticamente attivi
ES479054A0 (es) Procedimiento para la preparar monocariones por des-dicario-tizacion de cepas dicarioticas de basidiomicetos.
AR197158A1 (es) Procedimiento para la preparacion de una vacuna oral contra la gastroenteritis trasmisible porcina
BE833328A (fr) Procede de preparation de 6-chloro-2-chloro-methyl-4-phenylquinazoline-3-oxyde, et intermediaires appropries
IT959338B (it) Procedimento per la produzione del terreno di coltura di macrofunghi in particolare di funghi mangerec ci per la preparazione del vaccino industriale e per la coltivazione
IT960766B (it) Procedimento per la fabbricazione di denti artificiali
BR6349184D0 (pt) Processo para a preparacao de uma vacina viva contra a febre aftosa
AR200022A1 (es) Procedimiento para la fabricacion de fibras
ES2059605T3 (es) Vacuna toxoide de la tosferina.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 302781

Country of ref document: ES